Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme

Clinical trial NCT00890032 · COMPLETED

Trial details

NCT number: NCT00890032
Sponsor: John Sampson
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Central Nervous System Neoplasm

Start date: 2009-09-01
Primary completion: 2014-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.